TickerFacts.

MapLight Therapeutics, Inc. (MPLT): Cash & Equivalents

Annual figures by period end, from SEC filings.

$46.73M
As of 2025-12-31
$71.63M
As of 2026-06-30
2024-12-31: $38.25M2025-12-31: $46.73M$46.73M
2024-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$46.73M+22.2%2026-03-26, Balance as of period end
2024-12-31$38.25Mn/a2026-03-26, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
MapLight Therapeutics, Inc. (MPLT)2025-12-31$46.73M+22.2%
Rhythm Pharmaceuticals, Inc. (RYTM)2025-12-31$54.30M-39.1%
Enliven Therapeutics, Inc. (ELVN)2025-12-31$98.90M-20.3%
Oruka Therapeutics, Inc. (ORKA)2025-12-31$46.94M-23.8%
Vanda Pharmaceuticals Inc. (VNDA)2025-12-31$84.85M-17.1%
Ardelyx, Inc. (ARDX)2025-12-31$68.00M+4.7%
Biohaven Ltd. (BHVN)2025-12-31$229.96M+132.0%
Rapport Therapeutics, Inc. (RAPP)2025-12-31$52.65M-7.3%
BridgeBio Oncology Therapeutics, Inc. (BBOT)2025-12-31$373.69Mn/m

Compare MPLT, RYTM, ELVN, ORKA side by side · Screen every company in Pharmaceutical Preparations ↗